Person who experienced the adverse event (patient)
Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
118518603 | 11851860 | 3 | F | 20150514 | 20160912 | 20151218 | 20160916 | EXP | US-TAKEDA-2015TEU010561 | TAKEDA | 79.41 | YR | F | Y | 99.30000 | KG | 20160916 | MD | US | US |
Drug(s) used by person
Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
118518603 | 11851860 | 1 | PS | ACTOS | PIOGLITAZONE HYDROCHLORIDE | 1 | Oral | 30 MG, QD | 5340 | MG | Y | 21073 | 30 | MG | QD | ||||
118518603 | 11851860 | 2 | SS | IBUPROFEN. | IBUPROFEN | 1 | Oral | UNK | U | 0 | TABLET | ||||||||
118518603 | 11851860 | 3 | SS | IBUPROFEN. | IBUPROFEN | 1 | U | 0 | TABLET | ||||||||||
118518603 | 11851860 | 4 | C | LEVOTHYROXINE SODIUM. | LEVOTHYROXINE SODIUM | 1 | UNK | U | 0 | ||||||||||
118518603 | 11851860 | 5 | C | FUROSEMIDE. | FUROSEMIDE | 1 | UNK | U | 0 | ||||||||||
118518603 | 11851860 | 6 | C | PAROXETINE. | PAROXETINE | 1 | UNK | U | 0 | ||||||||||
118518603 | 11851860 | 7 | C | CELEBREX | CELECOXIB | 1 | UNK | U | 0 | ||||||||||
118518603 | 11851860 | 8 | C | OMEPRAZOLE. | OMEPRAZOLE | 1 | UNK | U | 0 | ||||||||||
118518603 | 11851860 | 9 | C | DOXAZOSIN | DOXAZOSINDOXAZOSIN MESYLATE | 1 | UNK | U | 0 | ||||||||||
118518603 | 11851860 | 10 | C | VITAMIN B6 | PYRIDOXINE HYDROCHLORIDE | 1 | UNK | U | 0 | TABLET | |||||||||
118518603 | 11851860 | 11 | C | ALDACTONE | SPIRONOLACTONE | 1 | UNK | U | 0 | ||||||||||
118518603 | 11851860 | 12 | C | PRAMIPEXOLE. | PRAMIPEXOLE | 1 | UNK | U | 0 | ||||||||||
118518603 | 11851860 | 13 | C | K DUR | 2 | UNK | U | 0 |
Indications of drugs used
Event ID | CASEID | INDI DRUG SEQ | INDI PT |
---|---|---|---|
118518603 | 11851860 | 1 | Type 2 diabetes mellitus |
118518603 | 11851860 | 2 | Osteoarthritis |
118518603 | 11851860 | 3 | Rheumatoid arthritis |
118518603 | 11851860 | 4 | Hypothyroidism |
118518603 | 11851860 | 5 | Oedema |
118518603 | 11851860 | 6 | Depression |
118518603 | 11851860 | 7 | Arthritis |
118518603 | 11851860 | 8 | Gastrooesophageal reflux disease |
118518603 | 11851860 | 9 | Hypertension |
118518603 | 11851860 | 10 | Supplementation therapy |
118518603 | 11851860 | 11 | Hypertension |
118518603 | 11851860 | 12 | Restless legs syndrome |
118518603 | 11851860 | 13 | Supplementation therapy |
Outcome of event
Event ID | CASEID | OUTC COD |
---|---|---|
118518603 | 11851860 | HO |
118518603 | 11851860 | OT |
Reactions reported
Event ID | CASEID | DRUG REC ACT | PT |
---|---|---|---|
118518603 | 11851860 | Arthritis | |
118518603 | 11851860 | Bradycardia | |
118518603 | 11851860 | Condition aggravated | |
118518603 | 11851860 | Dyspnoea | |
118518603 | 11851860 | Oedema peripheral |
Reporting Sources (this data is often not reported and may therefore be missing here)
no results found |
Therapies reported
Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
---|---|---|---|---|---|---|
118518603 | 11851860 | 1 | 20150131 | 20150729 | 0 | |
118518603 | 11851860 | 2 | 20120915 | 20130507 | 0 | |
118518603 | 11851860 | 4 | 20150723 | 0 | ||
118518603 | 11851860 | 5 | 20150718 | 0 | ||
118518603 | 11851860 | 6 | 20150704 | 0 | ||
118518603 | 11851860 | 7 | 20150514 | 0 | ||
118518603 | 11851860 | 8 | 20150515 | 0 | ||
118518603 | 11851860 | 9 | 20150714 | 0 | ||
118518603 | 11851860 | 10 | 20140128 | 0 | ||
118518603 | 11851860 | 11 | 20150306 | 0 | ||
118518603 | 11851860 | 12 | 201212 | 0 | ||
118518603 | 11851860 | 13 | 20121101 | 0 |